What Are These Clumps of Material in the MMR Vaccine?

September 6th, 2023

I have no idea what I’m looking at, but my guess is that there shouldn’t be visible clumps of whatever-that-is in any vaccine.

What is that?

If you have a PhD is a relevant field and want to go on the record to explain this to us, please email me.

Via: Ana Maria Mihalcea, MD, PhD:

NOBODY can justify injecting this material into babies.

Research Credit: pookie

3 Responses to “What Are These Clumps of Material in the MMR Vaccine?”

  1. NH says:

    Wolfgang Wodarg talks about the clumps of material in the Covid “vaccine” in a video interview, at minute 39:30:

    https://themelkshow.com/mel-k-dr-wolfgang-wodarg-never-again-we-must-not-let-the-crimes-of-covid-go-7-31-23/

  2. Kevin says:

    I haven’t received a single email from anyone telling me, that’s normal, nothing to see here, move along.

  3. Snowman says:

    From the Australian govt Sept. 4, 2023 (same date as Mihalcea’s article):

    Is it true? Can COVID-19 vaccines connect me to the internet?

    https://www.health.gov.au/our-work/covid-19-vaccines/is-it-true/is-it-true-can-covid-19-vaccines-connect-me-to-the-internet

    “Some of the mRNA vaccines being developed include the use of a material called a hydrogel, which might help disperse the vaccine slowly into our cells.

    Bioengineers have used similar hydrogels for many years in different ways. For instance, they’ve used them to help stem cells survive after being put inside our bodies.”

    From Nature Nanotechnology June 16, 2022::

    Characterization of nanoparticles-based vaccines for COVID-19

    https://www.nature.com/articles/s41565-022-01129-w

    “Several of these vaccines use organic nanoparticles (NPs) in their formulations for the protection and delivery of the active substance (AS)2. The AS is either a recombinant spike protein or a nucleic acid that encodes the viral antigen (the SARS-CoV-2 whole-spike protein or its subunits). Two vaccines authorized by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) use lipid NPs (LNP) to carry the mRNA that codifies for the spike protein of SARS-CoV-2. Owing to the size of the nanocarriers (NCs), usually between 50 and 200?nm, the complete formulation is generally referred to as a nanovaccine (NV). The NC in the formulation contributes to the overall immunomodulatory properties of the vaccine itself, in addition to the delivery and protection of the cargo3.”

    Lots more like these online.

Leave a Reply

You must be logged in to post a comment.